Literature DB >> 17991444

Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement.

Bruno A Paim1, Jesus A Velho, Roger F Castilho, Helena C F Oliveira, Aníbal E Vercesi.   

Abstract

We have previously proposed that hypercholesterolemic LDL receptor knockout (k/o) mice mitochondria possess a lower antioxidant capacity due to a large consumption of reducing equivalents from NADPH to sustain high rates of lipogenesis. In this work, we tested the hypothesis that this k/o mice mitochondrial oxidative stress results from the depletion of NADPH-linked substrates. In addition, the oxidative stress was further characterized by showing a lower mitochondrial GSH/GSSG ratio and a higher liver content of protein carbonyls as compared to controls. The activity of the antioxidant enzyme system glutathione reductase/peroxidase did not differ in k/o and control mitochondria. The faster spontaneous oxidation of endogenous NADPH in the k/o mitochondria was prevented by the addition of exogenous catalase, indicating that this oxidation is mediated by mitochondrially generated H(2)O(2). The higher rate of H(2)O(2) production was also prevented by the addition of exogenous isocitrate that maintains NADP fully reduced. The hypothesis that high rates of lipogenesis in the k/o cells decrease mitochondrial NADPH/NADP(+) ratio due to consumption of NADPH-linked substrates was supported by two findings: (i) oxygen consumption supported by endogenous NAD(P)H-linked substrates was slower in k/o than in control mitochondria, but was similar in the presence of exogenous isocitrate; (ii) in vivo treatment of k/o mice with sodium citrate/citric acid drinking solution for 2 weeks partially restored both the rate of oxygen consumption supported by NAD(P)H-linked substrates and the mitochondrial capacity to sustain reduced NADPH. In conclusion, the data demonstrate that the mitochondrial oxidative stress in hypercholesterolemic LDL receptor knockout mice is the result of a low content of mitochondrial NADPH-linked substrates in the intact animal that can be, at least in part, replenished by oral administration of citrate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991444     DOI: 10.1016/j.freeradbiomed.2007.10.005

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

1.  Diphenyl diselenide prevents cortico-cerebral mitochondrial dysfunction and oxidative stress induced by hypercholesterolemia in LDL receptor knockout mice.

Authors:  Jade de Oliveira; Eduardo Luiz Gasnhar Moreira; Gianni Mancini; Mariana Appel Hort; Alexandra Latini; Rosa Maria Ribeiro-do-Valle; Marcelo Farina; João Batista Teixeira da Rocha; Andreza Fabro de Bem
Journal:  Neurochem Res       Date:  2013-07-24       Impact factor: 3.996

Review 2.  Factors Responsible for Obesity-Related Hypertension.

Authors:  Kyungjoon Lim; Kristy L Jackson; Yusuke Sata; Geoffrey A Head
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

3.  Correlation between Mitochondrial Reactive Oxygen and Severity of Atherosclerosis.

Authors:  Gabriel G Dorighello; Bruno A Paim; Samara F Kiihl; Mônica S Ferreira; Rodrigo R Catharino; Anibal E Vercesi; Helena C F Oliveira
Journal:  Oxid Med Cell Longev       Date:  2015-11-09       Impact factor: 6.543

4.  Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease.

Authors:  Anna Hernández-Aguilera; Salvador Fernández-Arroyo; Noemí Cabre; Fedra Luciano-Mateo; Gerard Baiges-Gaya; Montserrat Fibla; Vicente Martín-Paredero; Javier A Menendez; Jordi Camps; Jorge Joven
Journal:  Mediators Inflamm       Date:  2018-09-20       Impact factor: 4.711

5.  Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury.

Authors:  Sergio Dellepiane; Davide Medica; Cesare Guarena; Tiziana Musso; Alessandro Domenico Quercia; Gianluca Leonardi; Marita Marengo; Massimiliano Migliori; Vincenzo Panichi; Luigi Biancone; Francesco Pizzarelli; Giovanni Camussi; Vincenzo Cantaluppi
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

6.  In Vivo Pravastatin Treatment Reverses Hypercholesterolemia Induced Mitochondria-Associated Membranes Contact Sites, Foam Cell Formation, and Phagocytosis in Macrophages.

Authors:  Leandro Henrique de Paula Assis; Gabriel de Gabriel Dorighello; Thiago Rentz; Jane Cristina de Souza; Aníbal Eugênio Vercesi; Helena Coutinho Franco de Oliveira
Journal:  Front Mol Biosci       Date:  2022-03-15

7.  Predictors of mean arterial pressure morning rate of rise and power function in subjects undergoing ambulatory blood pressure recording.

Authors:  Geoffrey A Head; Nick Andrianopoulos; Barry P McGrath; Catherine A Martin; Melinda J Carrington; Elena V Lukoshkova; Pamela J Davern; Garry L Jennings; Christopher M Reid
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

8.  Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility.

Authors:  Gunilla Grundström; Anders Christensson; Maria Alquist; Lars-Göran Nilsson; Mårten Segelmark
Journal:  BMC Nephrol       Date:  2013-10-09       Impact factor: 2.388

9.  Increased Susceptibility of Gracilinanus microtarsus Liver Mitochondria to Ca²⁺-Induced Permeability Transition Is Associated with a More Oxidized State of NAD(P).

Authors:  Juliana A Ronchi; Barbara Henning; Felipe G Ravagnani; Tiago R Figueira; Roger F Castilho; Sergio F dos Reis; Anibal E Vercesi
Journal:  Oxid Med Cell Longev       Date:  2015-10-25       Impact factor: 6.543

10.  Mild Mitochondrial Uncoupling Decreases Experimental Atherosclerosis, A Proof of Concept.

Authors:  Gabriel G Dorighello; Juliana C Rovani; Bruno A Paim; Thiago Rentz; Leandro H P Assis; Anibal E Vercesi; Helena C F Oliveira
Journal:  J Atheroscler Thromb       Date:  2021-06-04       Impact factor: 4.394

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.